ENTITY

Dynavax Technologies (DVAX US)

5
Analysis
Health Care • United States
Dynavax Technologies Corporation discovers, develops, and is seeking to commercialize products based on immunostimulatory sequences. The Company is developing products to treat and prevent allergies, infectious diseases, and chronic inflammatory diseases using approaches that alter immune system responses in specific ways.
more
Company Event • 27 Mar 2026 05:30 • Upcoming
Add To Calendar

Q4 2025

Company Event • 03 Dec 2025 03:10 • Latest

Evercore ISI 8th Annual HealthCONx Conference

Company Event • 06 Nov 2025 05:30

Q3 2025

Company Event • 04 Sep 2025 04:30

Wells Fargo 20th Annual Healthcare Conference 2025

Company Event • 08 Aug 2025 04:30

Q2 2025

x